Da Pang

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1

Hongzhong Li, Yi Xiao, Qin Li et al. · Cancer Cell · 2021 · 305 citations · Full text

Life Sciences, Immunology, Oncology +15

Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells

Shiyao Sui, Jiän Zhang, Shouping Xu et al. · Cell Death and Disease · 2019 · 225 citations · Full text

Medicine, Cell Biology, Oncology +14

Oncogenic long noncoding RNA landscape in breast cancer

Shouping Xu, Dejia Kong, Qianlin Chen et al. · Molecular Cancer · 2017 · 221 citations · Full text

Medicine, Genetics, Oncology +17

LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway

Kun Qiao, Shipeng Ning, Lin Wan et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 210 citations · Full text

Medicine, Molecular Biology, Oncology +17